Jingjing Pharmaceutical Co., Ltd. takes synthetic biology as its core driving force and relies on professional technical platforms such as biofermentation, bioenzyme catalysis, chemical synthesis, and crystal control. By integrating multidisciplinary technologies and innovative elements, the company focuses on its ability to transform research results and its advantages in industrial incubation. It has established a product matrix that includes specialty active pharmaceutical ingredients, amino acids, and vitamin nutritional fortifiers, providing support for various industries such as medicine, food, cosmetics, and agriculture through green biomanufacturing technologies, thus becoming a core value partner in the global health industry. **Technological Integration and Innovation:** By applying multiple disciplines in combination with the deep integration of technical platforms, Jingjing can select the most suitable production processes based on the characteristics of its products, thereby reducing production costs while ensuring product quality. **Strong Industrialization Capability:** The transition from the laboratory to the factory is not merely a simple scaling-up process; it requires re-innovation, engineering optimization, and market adaptation. Jingjing possesses the full-chain advantages from small-scale experiments to industrial production and has established a comprehensive innovation system that covers “strain modification, process optimization, product industrialization, and technology empowerment,” enabling the effective transformation of “scientific language” into “industrial language.” The company always adheres to the commitment of “meeting customer needs and exceeding expectations” and is committed to becoming a bridge between biotechnology and a healthy lifestyle. By using an open innovation platform to incubate new projects, it enhances the collaborative value of the industrial chain, creates value for customers worldwide, and contributes to the cause of human health.